Skip to main content
Clinical Trials/NCT01691716
NCT01691716
Completed
Not Applicable

A Prospective Randomized Study Comparing the Therapeutic Effect of Tendoactive®, Eccentric Training, and a Combination of Both as a Treatment of Achilles Tendinopathy

Bioiberica6 sites in 1 country100 target enrollmentApril 2012

Overview

Phase
Not Applicable
Intervention
Tendoactive
Conditions
Achilles Tendinopathy
Sponsor
Bioiberica
Enrollment
100
Locations
6
Primary Endpoint
Change from Baseline in VISA-A score at 12 weeks
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to determine whether Tendoactive, eccentric training, or the combination or both could be effective in the treatment of Achilles tendinopathy.

Registry
clinicaltrials.gov
Start Date
April 2012
End Date
September 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Bioiberica
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients suffering from a gradually evolving painful condition in the Achilles tendon located at the midportion for at least 3 months (Diagnosis based on clinical examination showing a painful thickening of the Achilles tendon located at a level of 2 to 6cm above the tendon insertion, and confirmed by ultrasonography: local thickening of the tendon, irregular tendon structure with hypoechoic areas and irregular fiber orientation).
  • Men and non-pregnant women aged 18-70 years
  • Be informed of the nature of the study and provide written informed consent.

Exclusion Criteria

  • Clinical suspicion of insertional disorders (pain at the site of the insertion of the Achilles tendon on the calcaneum)
  • Clinical suspicion of an Achilles tendon rupture (Thompson test abnormal and palpable "gap")
  • Clinical suspicion of plantar flexor tenosynovitis (posteromedial pain when the toes are plantar flexed against resistance)
  • Clinical suspicion of n.suralis pathology (sensitive disorder in the area of the sural nerve)
  • Clinical suspicion of peroneal subluxation
  • Suspicion of internal disorders: spondylarthropathy, gout, hyperlipidemia, Rheumatoid Arthritis and sarcoidosis.
  • Condition that prevents the patients from executing an active exercise programme
  • Patient has already performed eccentric exercises, according to the schedule of Alfredson et al (12 weeks)
  • Patient has already received an injection of PRP for this injury
  • Patient does not wish, for whatever reason, to undergo one of the two treatments

Arms & Interventions

Tendoactive and eccentric training

Tendoactive dosage: 3 capsules per day. Eccentric training: protocol described by Alfredson et al 1998 (Am J Sports Med 1998 26: 360)

Intervention: Tendoactive

Tendoactive and eccentric training

Tendoactive dosage: 3 capsules per day. Eccentric training: protocol described by Alfredson et al 1998 (Am J Sports Med 1998 26: 360)

Intervention: Eccentric training

Tendoactive

Tendoactive dosage: 3 capsules per day

Intervention: Tendoactive

Eccentric training

Protocol published by Alfredson et al 1998 (Am J Sports Med 1998 26: 360)

Intervention: Eccentric training

Outcomes

Primary Outcomes

Change from Baseline in VISA-A score at 12 weeks

Time Frame: 12 weeks

Functional impairment of the Achilles tendon is measured using VISA-A score. Score of patient-related outcome measure: Achilles tendon: VISA-A \[0=worse, 100=perfect\] derived from eight validated questions on pain and function during activities of daily living

Secondary Outcomes

  • Pain level at rest [VAS 0-10](0, 6, 12 weeks)
  • Pain level at exertion [VAS 0-10](0, 6, 12weeks)
  • Achilles transverse thickness by ultrasound(0, 6, 12 weeks)
  • SF-36 v2 quality of life survey(0, 12 weeks)
  • Patient satisfaction(6, 12 weeks)

Study Sites (6)

Loading locations...

Similar Trials